David J. Mauro, Chief Medical Officer at Prelude Therapeutics Inc (PRLD), sold 25,000 shares at $30.82 ($772K) on 2021-04-19, disclosed to the SEC on 2021-04-21.
Open-market sale of $772k PRLD by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.82 | 21,000 | $647K | 83.8% |
| 2 | $31.27 | 4,000 | $125K | 16.2% |
| Total | $30.89 avg | 25,000 | $772K | 100% |
| Filing → |
| PRLD | SELL | 2021-08-09 | $930K | — | Filing → |
| PRLD | SELL | 2021-07-08 | $816K | — | Filing → |
| PRLD | SELL | 2021-06-09 | $902K | — | Filing → |